Talc Victims to Johnson & Johnson: There's No Escaping Science Linking Talc with Ovarian Cancer and MesotheliomaBusiness Wire • 06/07/23
Analysis: Stelara patent deal puts J&J back on path to $57 bln 2025 revenue forecastReuters • 06/05/23
Johnson & Johnson (JNJ) Bernstein's 39th Annual Strategic Decisions Conference 2023 Call TranscriptSeeking Alpha • 05/31/23